Registered outcomes18

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 18 of 18

List	Outcome	Time frame	Description
Primary	Phase 2: Predicted Annualized Growth Velocity (AGV) at Week 52 (based on AGV at Weeks 26, 39, and 52 [available cumulative data]	52 weeks
Primary	Phase 3: Annualized Growth Velocity (AGV) at Week 52	52 weeks
Secondary	Phase 2: AGV at Weeks 26 and 52	26 and 52 weeks
Secondary	Phase 2: Change from Baseline in standing height	26 and 52 weeks	Measured in centimeters
Secondary	Phase 2: Change from Baseline in height Z-score	26 and 52 weeks
Secondary	Phase 2: Change from Baseline in upper to lower body segment ratio	26 and 52 weeks
Secondary	Phase 2: Incidence of adverse events (AEs)	52 weeks
Secondary	Phase 2: Incidence of serious adverse events (SAEs)	52 weeks
Secondary	Phase 2: Incidence of events of interest (EOIs)	52 weeks
Secondary	Phase 2: Maximum concentration (Cmax) of BMN 333 in plasma	52 weeks
Secondary	Phase 2: Maximum concentration (Cmax) of released vosoritide in plasma	52 weeks
Secondary	Phase 2: Time to reach maximum concentration (Tmax) for BMN 333	52 weeks
Secondary	Phase 2: Time to reach maximum concentration (Tmax) for released vosoritide	52 weeks
Secondary	Phase 2: Lowest concentration (C trough) of BMN 333 in plasma	52 weeks
Secondary	Phase 2: Lowest concentration (C trough) of released vosoritide in plasma	52 weeks
Secondary	Phase 3: Change from Baseline in standing height	52 weeks	Measured in centimeters
Secondary	Phase 3: Change from Baseline in height Z-score	52 weeks
Secondary	Phase 3: Change from Baseline in upper to lower body segment ratio	52 weeks

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT07441876/registered